2019
DOI: 10.1016/j.clim.2019.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Candidiasis associated with very early onset inflammatory bowel disease: First IL10RB deficient case from the National Iranian Registry and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 40 publications
1
8
0
Order By: Relevance
“…IL-10 was also related with greater inflammatory markers in the sepsis group. According to the research, IL-10 is produced by a variety of cells and has a crucial function in limiting the production of proinflammatory cytokines, such as IL-12, which are generated when a person is inflamed (26). In the infected group, there was a positive correlation between IL-17 levels and IL-8, but in the sepsis group, there was a positive correlation between IL-6 and IL-8, showing that IL-17 is better able to react to inflammation markers.…”
Section: Discussionmentioning
confidence: 99%
“…IL-10 was also related with greater inflammatory markers in the sepsis group. According to the research, IL-10 is produced by a variety of cells and has a crucial function in limiting the production of proinflammatory cytokines, such as IL-12, which are generated when a person is inflamed (26). In the infected group, there was a positive correlation between IL-17 levels and IL-8, but in the sepsis group, there was a positive correlation between IL-6 and IL-8, showing that IL-17 is better able to react to inflammation markers.…”
Section: Discussionmentioning
confidence: 99%
“…These clinical observations are consistent with the incomplete blockade of IL-17 receptor signaling conferred by these monoclonal antibodies at the mucocutaneous barrier (116,117), as opposed to the complete abrogation of IL-17 receptor signaling in patients with inherited complete deficiencies of the IL-17 receptors IL-17RA and IL-17RC and of the IL-17 receptor adaptor ACT1 who develop CMC with complete penetrance (118)(119)(120). Furthermore, patients with inherited IL-10RB deficiency whose cells do not respond to IL-22 (nor to IL-10, IL-26, IL-28, and IFNL1) do not develop CMC; a single case of treatment-responsive OPC in the absence of iatrogenic immunosuppression has been reported in IL-10RB-deficient patients (OPC frequency, ∼3%) who develop very severe early-onset inflammatory bowel disease requiring treatment with corticosteroids and/or TNF-α inhibitors (121)(122)(123). Taken together, although APECED patients harbor neutralizing autoantibodies against type-17 cytokines, their presence is unlikely to be the sole factor that might contribute to CMC in the APECED population (124).…”
Section: Autoantibodies Against Type-17 Cytokines Ifn-γ-driven Defects In Oral Epithelial Barrier and Cmcmentioning
confidence: 99%
“…However, the impact of pathogenic IL10RB variants on IL-10RB-dependent cytokine response pathways has not been studied experimentally. Predicted loss-of-function (pLOF) variants of IL10RB have been reported to cause a premature termination of translation in various domains of the protein, whereas missense pathogenic mutations are clustered in the extracellular domain [44,48,50,52,[56][57][58] (Fig. 1D).…”
Section: Impaired Production and Glycosylation Of The W100g Proteinmentioning
confidence: 99%